Search
Fulcrum Therapeutics’ CEO discusses the clinical hold lift of the company’s SCD program.
Alex Sapir explains a tweak in the clinical trial population that allowed the trial to resume.
Aug 23, 2023
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.
bottom of page